NDC 51079-889-19
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-889
- Requested NDC
- 51079-889-19
- Package NDCs from labels
- 51079-889-19
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-889-01 | EA - Each | 51079-889 | 296d706a-0346-4d47-aff8-9ff37e82d0b7 | 1 | 2013-02-13 |
| 51079-889-17 | EA - Each | 51079-889 | 1687b1d2-2435-43f1-bf5e-4701668b7ffc | 1 | 2013-02-13 |
| 51079-889-19 | EA - Each | 51079-889 | a046bf15-4824-41e4-b20e-7cbe644312bb | 1 | 2013-02-13 |
| 51079-889-20 | EA - Each | 51079-889 | ea750ebd-7f1d-4980-9ac6-5046af5c61be | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pentoxifylline | PENTOXIFYLLINE | Rising Pharma Holdings, Inc. | cd840a2c-2a0e-4b2b-84ff-a0406bb6fa37 | 2026-05-15 | Adverse reactions | ANDA074425 |
| Pentoxifylline | PENTOXIFYLLINE | Bryant Ranch Prepack | c3ad4fb4-8995-46ab-86e9-7ec67ef607f9 | 2025-04-07 | Adverse reactions | ANDA074425 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.